Patents by Inventor Peter Ravn

Peter Ravn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190092877
    Abstract: This application provides anti-PCSK9˜GLP-1 fusions and methods for use.
    Type: Application
    Filed: September 17, 2018
    Publication date: March 28, 2019
    Inventors: Anthony CELESTE, Matthieu CHODORGE, Andrew BUCHANAN, Cristina RONDINONE, Joseph GRIMSBY, Peter RAVN, Jonathan SEAMAN, David FAIRMAN
  • Patent number: 10077319
    Abstract: This application provides anti-PCSK9˜GLP-1 fusions and methods for use.
    Type: Grant
    Filed: February 20, 2015
    Date of Patent: September 18, 2018
    Assignees: MedImmune, LLC, MedImmune Limited
    Inventors: Anthony Celeste, Matthieu Chodorge, Andrew Buchanan, Cristina Rondinone, Joseph Grimsby, Peter Ravn, Jonathan Seaman, David Fairman
  • Publication number: 20160369010
    Abstract: This application provides anti-PCSK9˜GLP-1 fusions and methods for use.
    Type: Application
    Filed: February 20, 2015
    Publication date: December 22, 2016
    Inventors: Anthony Celeste, Matthieu CHODORGE, Andrew BUCHANAN, Cristina RONDINONE, Joseph GRIMSBY, Peter RAVN, Jonathan SEAMAN, David FAIRMAN
  • Publication number: 20160185837
    Abstract: This disclosure provides GIP/GLP-1 dual agonist polypeptides for the treatment of hypoglycemic conditions, e.g., type-2 diabetes.
    Type: Application
    Filed: August 15, 2014
    Publication date: June 30, 2016
    Applicant: Medimmune Limited
    Inventors: Maria Bednarek, Andie Collinson, David Hornigold, Siobhan O'Brien, Monika Papworth, Peter Ravn, Isabelle Sermadiras
  • Patent number: 9345794
    Abstract: The invention relates to recognition molecules which are directed towards tumors and can be used in the diagnosis and therapy of tumor diseases.
    Type: Grant
    Filed: December 10, 2013
    Date of Patent: May 24, 2016
    Assignee: Glycotype GmbH
    Inventors: Steffen Goletz, Antje Danielczyk, Uwe Karsten, Peter Ravn, Renate Stahn, Peter Astrup Christensen
  • Publication number: 20140099259
    Abstract: The invention relates to recognition molecules which are directed towards tumors and can be used in the diagnosis and therapy of tumor diseases.
    Type: Application
    Filed: December 10, 2013
    Publication date: April 10, 2014
    Applicant: Glycotope GmbH
    Inventors: Steffen Goletz, Antje Danielczyk, Uwe Karsten, Peter Ravn, Renate Stahn, Peter Astrup Christensen
  • Patent number: 8617846
    Abstract: The invention relates to recognition molecules which are directed towards tumors and can be used in the diagnosis and therapy of tumor diseases.
    Type: Grant
    Filed: November 22, 2011
    Date of Patent: December 31, 2013
    Assignee: Glycotope GmbH
    Inventors: Steffen Goletz, Antje Danielczyk, Uwe Karsten, Peter Ravn, Renate Stahn, Peter Astrup Christensen
  • Publication number: 20120149877
    Abstract: The invention relates to recognition molecules which are directed towards tumors and can be used in the diagnosis and therapy of tumor diseases.
    Type: Application
    Filed: November 22, 2011
    Publication date: June 14, 2012
    Applicant: GLYCOTOPE GMBH
    Inventors: Steffen Goletz, Antje Danielczyk, Uwe Karsten, Peter Ravn, Renate Stahn, Peter Astrup Christensen
  • Patent number: 8088357
    Abstract: The invention relates to recognition molecules which are directed towards tumors and can be used in the diagnosis and therapy of tumor diseases.
    Type: Grant
    Filed: December 1, 2003
    Date of Patent: January 3, 2012
    Assignee: Nemod Biotherapeutics GmbH & Co. KG
    Inventors: Steffen Goletz, Antje Danielczyk, Uwe Karsten, Peter Ravn, Renate Stahn, Peter Astrup Christensen
  • Patent number: 7358067
    Abstract: The invention provides a fed-batch or continuous process for producing heterologous peptides, polypeptides or proteins in lactic acid bacteria, comprising the steps of (i) constructing a recombinant lactic acid bacterium comprising a nucleotide sequence coding for the heterologous peptide, polypeptide or protein, and appropriate regulatory nucleotide sequences such as regulatable promoters and signal peptides to control the expression of the coding sequence and the secretion of gene product, (ii) cultivating the recombinant bacterium under or continuous cultivation conditions to express the gene, and (iii) harvesting the recombinant bacterium or the gene product. Preferably, the cultivation medium is a chemically defined or synthetic medium optionally supplemented with yeast extract.
    Type: Grant
    Filed: October 19, 2001
    Date of Patent: April 15, 2008
    Assignee: Bioneer A/S
    Inventors: Astrid Vrang, Søren Michael Madsen, Lars Bredmose, Peter Ravn, Jose Arnau, Mads Gronvald Johnsen, Anne Cathrine Steenberg, Hans Israelsen
  • Patent number: 7186815
    Abstract: A method of identifying nucleotide sequences coding for signal peptides in lactic acid bacteria, using a DNA molecule comprising a transposon including a promoterless reporter gene from which DNA molecule a region between the LR and the reporter gene is deleted and the DNA molecule comprises a DNA sequence coding for a secretion reporter molecule. By deleting the region between the LR and the reporter gene, stop codons in-frame with the secretion reporter molecule is removed which upon transposition permits translational fusions from upstream the LR.
    Type: Grant
    Filed: May 8, 2003
    Date of Patent: March 6, 2007
    Assignee: Bioneer A/S
    Inventors: Peter Ravn, Soeren Michael Madsen, Astrid Vrang, Hans Israelsen, Mads Groenvold Johnsen, Lars Bredmose, José Arnau
  • Publication number: 20060251668
    Abstract: The invention relates to recognition molecules which are directed towards tumors and can be used in the diagnosis and therapy of tumor diseases.
    Type: Application
    Filed: December 1, 2003
    Publication date: November 9, 2006
    Inventors: Steffen Goletz, Antje Danielczyk, Uwe Karsten, Peter Ravn, Renate Stahn, Peter Christensen
  • Publication number: 20040038263
    Abstract: A method of identifying nucleotide sequences coding for signal peptides in lactic acid bacteria, using a DNA molecule comprising a transposon including a promoterless reporter gene from which DNA molecule a region between the LR and the reporter gene is deleted and the DNA molecule comprises a DNA sequence coding for a secretion reporter molecule. By deleting the region between the LR and the reporter gene, stop codons in-frame with the secretion reporter molecule is removed which upon transposition permits translational fusions from upstream the LR.
    Type: Application
    Filed: May 8, 2003
    Publication date: February 26, 2004
    Applicant: Bioteknologisk Institut
    Inventors: Peter Ravn, Soeren Michael Madsen, Astrid Vrang, Hans Israelsen, Mads Groenvold Johnsen, Lars Bredmose, Jose Arnau
  • Publication number: 20030082778
    Abstract: Nucleotide sequences coding for a promoter activity-regulating polypeptide designated OrfY, isolated from Lactococcus lactis, and promoter activity-regulating active homologues and fragments hereof is used to indirectly regulating the expression of genes. The coding sequence is inserted into lactic acid bacterial cells or any other cells with the objective of either reducing or enhancing the expression level of the gene being under the control of the promoter sequence, the activity of which is regulated by the OrfY polypeptide or homologues or fragments hereof. Improved gene expression systems are provided based on this promoter activity-regulating polypeptide.
    Type: Application
    Filed: October 19, 2001
    Publication date: May 1, 2003
    Inventors: Soren Michael Madsen, Astrid Vrang, Lars Bredmose, Peter Ravn, Jacob Glenting, Mads Gronvald Johnsen, Hans Israelsen
  • Publication number: 20020137140
    Abstract: or continuous process for producing heterologous peptides, polypeptides or proteins in lactic acid bacteria, comprising the steps of (i) constructing a recombinant lactic acid bacterium comprising a nucleotide sequence coding for the heterologous peptide, polypeptide or protein, and appropriate regulatory nucleotide sequences such as regulatable promoters and signal peptides to control the expression of the coding sequence and the secretion of gene product, (ii) cultivating the recombinant bacterium under or continuous cultivation conditions to express the gene, and (iii) harvesting the recombinant bacterium or the gene product. Preferably, the cultivation medium is a chemically defined or synthetic medium optionally supplemented with yeast extract.
    Type: Application
    Filed: October 19, 2001
    Publication date: September 26, 2002
    Inventors: Astrid Vrang, Soren Michael Madsen, Lars Bredmose, Peter Ravn, Jose Arnau, Mads Gronvald Johnsen, Anne Cathrine Steenberg, Hans Israelsen
  • Patent number: 6133023
    Abstract: Expression vectors capable of being replicated in lactic acid bacterial cells comprising a promoter region comprising (a) a promoter sequence element the function of which is regulatable by an environmental or growth condition factor and (b) at least one further nucleotide sequence element, the position, orientation, presence and/or sequence of which element has a regulatory effect on the expression of a gene operably linked to the promoter region in which vectors the position, orientation, presence and/or sequence of at least one of said elements (a) or (b) is modified relative to the position, orientation, presence and/or sequence of the corresponding non-modified element whereby the expression of the gene is altered, and a lactic acid bacterium which is transformed with such a vector as defined above are provided.
    Type: Grant
    Filed: December 29, 1997
    Date of Patent: October 17, 2000
    Assignee: Bioteknologisk Institut
    Inventors: Soeren Michael Madsen, Astrid Vrang, Jose Arnau, Peter Ravn, Mads Groenvald Johnsen, Hans Israelsen